How to Learn Data science from scratch
Someone asked me recently how he could get the knowledge and the skills necessary to become a Data Scientist. There are different ways to learn data science, go to university, follow a bachelor or master in data science, get into a Bootcamp program, or learn it by yourself. Nowadays a lot of material is available on the internet, often for free, to learn the skills necessary for Data Science. There are three primary skills needed for Data Science 1) A programming language used in the data ecosystem, typically one of Python/R or Scala 2) SQL, for data manipulation and extraction, and 3) Statistics & Machine Learning. Python Assuming this is your first programming language, Python is an excellent language to learn. It is a general-purpose programming language with a broad ecosystem of data libraries. It is also relatively straight forward to learn and is often taught in introductory classes for computer science. It is good to start with a general introduction to computer science, rat
Coronavirus (Covid-19) vaccine latest update: As countries scramble to stem the spread of Covid-19, the US government’s top infectious disease expert, Anthony Fauci, has provided some hope of a vaccine being ready as early as November even as epidemiology experts have warned that the novel coronavirus might not go away with the development of an injection.
The experts have said the novel coronavirus would likely remain for years to come, and may eventually, become endemic like HIV, measles and chickenpox, a report in The Washington Post said.
According to the World Health Organization (WHO), more than 100 vaccines are being developed across the world,
with 10 candidates already in human trials. Till date, China’s CanSino adenovirus vaccine, Oxford University’s adenovirus vaccine, Moderna’s mRNA vaccine and Novavax have emerged as the top most promising vaccine candidates for Covid-19.
Coronavirus (Covid-19) vaccine latest updates:
💉 Shares of Moderna Inc, which last week reported successful results from its experimental vaccine, tumbled this week after a report highlighted side effects in a volunteer taking part in a trial
A volunteer told STAT News that he started getting chills within hours of getting home from his second dose and had nausea and aching muscles. He said he had received the highest dose from the trials — one 10 times stronger than others. However, he maintained that as sick as he was, it was never “life-threatening”, according to report in The New York Post.
READ | What govt said on vaccines being developed in India
Moreover, Moderna Inc, which said its candidate produced protective antibodies in a small group of healthy volunteers, has extended a deal with pharmaceutical ingredient supplier CordenPharma to secure large volumes of the lipids used to produce its vaccine, Reuters reported.
Moderna plans to supply millions of doses per month in 2020 and tens of millions a month in 2021 if the vaccine proves successful.